✦ LIBER ✦

Innovative productivity and returns to scale in the pharmaceutical industry

✍ Scribed by Samuel B. Graves; Nan S. Langowitz

Book ID: 112207734
Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 1005 KB
Volume: 14
Category: Article
ISSN: 0143-2095
DOI: 10.1002/smj.4250140803

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estimating productivity and returns to s

Estimating productivity and returns to scale in the US textile industry

✍ Harri Ramcharran 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 85 KB

Returns to research and development in t

Returns to research and development in the us pharmaceutical industry

✍ John R. Virts; J. Fred Weston 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 908 KB

Procyclical Productivity and Returns-to-

Procyclical Productivity and Returns-to-Scale in Philippine Manufacturing

✍ Tatsufumi Yamagata 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

Innovative output and firm size in the p

Innovative output and firm size in the pharmaceutical industry

✍ Samuel B. Graves; Nan S. Langowitz 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 814 KB

Innovation, R&D productivity, and global

Innovation, R&D productivity, and global market share in the pharmaceutical industry

✍ Donald L. Alexander; Joseph E. Flynn; Linda A. Linkins 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 876 KB

Product innovation, product–market compe

Product innovation, product–market competition and persistent profitability in the U.S. pharmaceutical industry

✍ Peter W. Roberts 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

Increasingly, strategy scholars are exploring the relationships between innovation, competition, and the persistence of superior profits. Sustained high profitability may result when a firm repeatedly introduces valuable innovations that service previously unmet consumer demands. While the returns t